Drexel University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Drexel University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12408
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Drexel University (Drexel) is a research university which provides educational degrees and research programs. The university offers courses for undergraduate courses, graduate and professional courses, adult education programs, colleges and schools, libraries and online training services. It also provides professional degree programs in architecture, science, chemical engineering, civil engineering, construction management, culinary science, nutrition and food, information systems and sports management. Drexel University also conducts research programs. The university operates through its campuses in various cities throughout the US. Drexel is headquartered in Philadelphia, Pennsylvania, the US.

Drexel University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Drexel University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Drexel University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Drexel University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Drexel University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Drexel University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Drexel University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CytoDyn Amends Research Agreement with Drexel University College of Medicine 10
Licensing Agreements 11
Oncore Biopharma Enters into Licensing Agreement with Baruch S. Blumberg Institute and Drexel University 11
Oncore Biopharma Enters into Licensing Agreement with Baruch S. Blumberg Institute and Drexel University 12
OnCore Biopharma Enters into Licensing Agreement with Drexel University 13
Drexel University – Key Competitors 14
Drexel University – Key Employees 15
Drexel University – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Strategy And Business Planning 17
Apr 16, 2018: Geisinger expands access to clinical trials through consortium with five other health systems 17
Government and Public Interest 19
Jun 21, 2018: Medicaid Expansion Under the ACA Increased Low-Income Patient Access to Kidney Transplants 19
Apr 16, 2018: Drexel Joins Regional Health Systems to Expand Access to Clinical Trials 21
Apr 16, 2018: Six Health Systems form Consortium to Expand Access to Clinical Trials, Bringing Access to Clinical Trials Closer to Home 22
Oct 05, 2017: Multivitamin Use During Pregnancy Linked to Lower Risk of Autism With Intellectual Disability 23
Sep 07, 2017: NIH awards nearly $100 million for Autism Centers of Excellence program 24
Jun 06, 2017: Study Identifies an Enzyme Inhibitor to Treat Gulf War Illness Symptoms 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Drexel University, Pharmaceuticals & Healthcare, Key Facts 2
Drexel University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Drexel University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Drexel University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Drexel University, Deals By Therapy Area, 2012 to YTD 2018 8
Drexel University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CytoDyn Amends Research Agreement with Drexel University College of Medicine 10
Oncore Biopharma Enters into Licensing Agreement with Baruch S. Blumberg Institute and Drexel University 11
Oncore Biopharma Enters into Licensing Agreement with Baruch S. Blumberg Institute and Drexel University 12
OnCore Biopharma Enters into Licensing Agreement with Drexel University 13
Drexel University, Key Competitors 14
Drexel University, Key Employees 15
Drexel University, Other Locations 16
Drexel University, Subsidiaries 16

List of Figures
Drexel University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Drexel University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Drexel University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Drexel University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Drexel University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Drexel University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Drexel University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Drexel University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Drexel University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Equipos Nucleares SA:企業の戦略的SWOT分析
    Equipos Nucleares SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Mitsui Fudosan Co Ltd (8801):企業の財務・戦略的SWOT分析
    Mitsui Fudosan Co Ltd (8801) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Nanobiotix SA (NANO):企業の財務・戦略的SWOT分析
    Summary Nanobiotix SA (Nanobiotix) is a late stage clinical company which develops nanomedicines for the treatment of cancers. The company develops first-in-class products utilizing its proprietary technology NanoXray, based on the physical mode of action of nanoparticles that increase the X-rays do …
  • Lendlease Corporation Limited (LLC):企業の戦略的SWOT分析
    Lendlease Corporation Limited (LLC) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Deutsche Borse Ag
    Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report Summary Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Atox Bio Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Atox Bio Ltd (Atox Bio) is a biotechnology company that develops immunomodulators to treat critically ill patients with severe infections. The company develops drugs for patients suffering from necrotizing soft tissue infections, a flesh eating bacteria. It offers AB103, known as the accute …
  • Retail Food Group Limited (Foodservice):企業の戦略・SWOT・財務情報
    Retail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Retail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Faes Farma SA (FAE):製薬・医療:M&Aディール及び事業提携情報
    Summary Faes Farma SA (Faes Farma) develops, manufactures and commercializes pharmaceutical products and raw materials. The company offers prescription drugs, generic drugs, food supplements, over-the-counter (OTC) medications, baby foods, skin-care treatment products. It exports raw-materials and f …
  • Galp Energia SGPS SA (GALP)-石油・ガス分野:企業M&A・提携分析
    Summary Galp Energia SGPS S.A. (Galp Energia) is an integrated oil and natural gas company. It explores for, develops and produces crude oil and natural gas; refines crude oil and markets refined petroleum products. The company also imports, transports and distributes natural gas. It conducts the na …
  • Thai Airways International Public Co Ltd
    Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Hino Motors Ltd (7205):企業の財務・戦略的SWOT分析
    Hino Motors Ltd (7205) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Pteris Global Ltd:企業の戦略・SWOT・財務情報
    Pteris Global Ltd - Strategy, SWOT and Corporate Finance Report Summary Pteris Global Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Amgen Inc (AMGN):企業の財務・戦略的SWOT分析
    Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cherry Rocher Neyret Chavin SA:企業の戦略・SWOT・財務情報
    Cherry Rocher Neyret Chavin SA - Strategy, SWOT and Corporate Finance Report Summary Cherry Rocher Neyret Chavin SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Banco Nacional de Obras y Servicios Publicos SNC:企業の戦略・SWOT・財務情報
    Banco Nacional de Obras y Servicios Publicos SNC - Strategy, SWOT and Corporate Finance Report Summary Banco Nacional de Obras y Servicios Publicos SNC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Ghella SpA:企業の戦略・SWOT・財務情報
    Ghella SpA - Strategy, SWOT and Corporate Finance Report Summary Ghella SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • IHI Corp (7013):電力:M&Aディール及び事業提携情報
    Summary IHI Corp (IHI) is a heavy machinery manufacturer. It provides technology oriented products and services to customers in the public, private and industrial sectors across the world. The group designs and manufactures a diverse range of products that includes ships and offshore facilities, str …
  • International Business Machines Corporation:企業の戦略・SWOT・財務情報
    International Business Machines Corporation - Strategy, SWOT and Corporate Finance Report Summary International Business Machines Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Intas Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Intas Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Tecan Group Ltd (TECN):製薬・医療:M&Aディール及び事業提携情報
    Summary Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation sup …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆